Oruka Therapeutics, Inc. (ORKA) Current Reports & Earnings Releases
Upcoming
- 2026-11-20 Earnings Release Estimated
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-24 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2026-08-10 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-06-04 | 8-K | Shareholder Vote Results | SEC |
| 2026-06-01 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2026-04-30 | 8-K | Results of Operations, Other Events, Financial Statements & Exhibits | SEC |
| 2026-04-27 | 8-K | Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2025-12-11 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2025-09-22 | 8-K | Material Agreement, Unregistered Sales, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-07-01 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2025-06-03 | 8-K | Shareholder Vote Results | SEC |
| 2025-02-05 | 8-K | Material Agreement | SEC |
| 2024-12-19 | 8-K | Material Agreement | SEC |
| 2024-11-18 | 8-K | Shareholder Vote Results | SEC |
| 2024-11-14 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-10-04 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2024-09-13 | 8-K | Material Agreement, Unregistered Sales, Charter Amendments, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-09-05 | 8-K | Material Agreement, Acquisition or Disposition, Results of Operations, Item 3.03, Auditor Change, Change in Control, Officer / Director Changes, Charter Amendments, Item 5.05, Item 5.06, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-08-27 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-08-23 | 8-K | Shareholder Vote Results, Other Events, Financial Statements & Exhibits | SEC |
| 2024-08-16 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-08-15 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2024-08-01 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-07-09 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2024-04-25 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-04-23 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2024-04-04 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2024-04-03 | 8-K | Material Agreement, Unregistered Sales, Change in Control, Officer / Director Changes, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-03-22 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2024-02-06 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2024-02-01 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-01-31 | 8-K | Officer / Director Changes, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.